Deals involving financially distressed entities are increasing in the health-care industry, and will continue making up a large part of the market, attorneys who counsel clients in the area told me.
Jeremy Johnson, a Polsinelli lawyer in New York, pointed to an index compiled by his firm that tracks bankruptcies in the space—the number has grown 20 percent since 2010. Johnson doesn’t see any probability of the trend reversing, meaning there are lots of good deals to be had in the industry.
But Spalding & King Atlanta partner Tom Hawk advises proceeding carefully. These deals come with their own challenges for both sellers and buyers.
The decision to sell is often a “numbers issue,” Hawk said. A hospital simply doesn’t have the funds needed to compete or bring its systems into compliance with government regulations. Sellers are looking for buyers who can provide the funds and rescue the provider, possibly saving the only hospital in a rural area.
But the aging of the American population, with its increasing dependence on Medicare to pay for health care, makes it very hard to operate in these locations, Hawk said.
And even long prior to closing the deal, conducting due diligence can get complicated for the buyer. Many people with key knowledge may have jumped ship by this point, and compliance programs could have received short shrift in light of the more pressing problem of keeping the hospital afloat.
Putting the distressed hospital through bankruptcy has many benefits—mostly because it results in the discharge of many debts. But it also has some disadvantages, especially if the entity’s financial problems weren’t well known before the bankruptcy petition was filed publicly.
Read my story about the reasons hospitals become financially distressed and how the deal process works when these entities are involved here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)